EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Machine Learning-Based Prognostic Signature in Breast Cancer: Regulatory T Cells, Stemness, and Deep Learning for Synergistic Drug Discovery

Samina Gul, Jianyu Pang, Yongzhi Chen iD, Qi Qi, Yuheng Tang, Yingjie Sun, Hui Wang iD, Wenru Tang iD, Xuhong Zhou

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26146995 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Samina Gul und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Genetics of Aging & Tumor, Medical School, Kunming University of Science and Technology, 727 Jingming South Road, Kunming 650…. Hauptthemen laut MEDLINE: Breast Neoplasms, T-Lymphocytes, Regulatory, Drug Discovery, Deep Learning. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kunming University of Science and Technology Medical joint project, Special fund project for central government leading local science and technology development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Regulatory T cells (Tregs) have multiple roles in the tumor microenvironment (TME), which maintain a balance between autoimmunity and immunosuppression. This research aimed to investigate the interaction between cancer stemness and Regulatory T cells (Tregs) in the breast cancer tumor immune microenvironment. Breast cancer stemness was calculated using one-class logistic regression. Twelve main cell clusters were identified, and the subsequent three subsets of Regulatory T cells with different differentiation states were identified as being closely related to immune regulation and metabolic pathways. A prognostic risk model including MEA1, MTFP1, PASK, PSENEN, PSME2, RCC2, and SH2D2A was generated through the intersection between Regulatory T cell differentiation-related genes and stemness-related genes using LASSO and univariate Cox regression. The patient’s total survival times were predicted and validated with AUC of 0.96 and 0.831 in both training and validation sets, respectively; the immunotherapeutic predication efficacy of prognostic signature was confirmed in four ICI RNA-Seq cohorts. Seven drugs, including Ethinyl Estradiol, Epigallocatechin gallate, Cyclosporine, Gentamicin, Doxorubicin, Ivermectin, and Dronabinol for prognostic signature, were screened through molecular docking and found a synergistic effect among drugs with deep learning. Our prognostic signature potentially paves the way for overcoming immune resistance, and blocking the interaction between cancer stemness and Tregs may be a new approach in the treatment of breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsT-Lymphocytes, RegulatoryDrug DiscoveryDeep LearningNeoplastic Stem CellsMachine LearningHumansFemalePrognosisTumor MicroenvironmentMolecular Docking SimulationGene Expression Regulation, NeoplasticBiomarkers, Tumor

Stichwörter der Autor:innen

breast cancerdeep learningmachine learningregulatory T cellsstemness

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Laboratory of Molecular Genetics of Aging & Tumor, Medical School, Kunming University of Science and Technology, 727 Jingming South Road, Kunming 650500, China.
  • State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming 650500, China.
  • Office of Science and Technology, Yunnan University of Chinese Medicine, Kunming 650500, China.

ORCID-Profile: Yongzhi Chen, Hui Wang, Wenru Tang

Förderung

  • Kunming University of Science and Technology Medical joint project
  • Special fund project for central government leading local science and technology development

Zitieren

APA

Gul, S., Pang, J., Chen, Y., Qi, Q., Tang, Y., Sun, Y., Wang, H., Tang, W., & Zhou, X. (2025). Machine Learning-Based Prognostic Signature in Breast Cancer: Regulatory T Cells, Stemness, and Deep Learning for Synergistic Drug Discovery. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26146995

Vancouver

Gul S, Pang J, Chen Y, Qi Q, Tang Y, Sun Y, et al. Machine Learning-Based Prognostic Signature in Breast Cancer: Regulatory T Cells, Stemness, and Deep Learning for Synergistic Drug Discovery. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26146995

BibTeX
@article{Gul2025,
  author = {Gul, Samina and Pang, Jianyu and Chen, Yongzhi and Qi, Qi and Tang, Yuheng and Sun, Yingjie and Wang, Hui and Tang, Wenru and Zhou, Xuhong},
  title = {Machine Learning-Based Prognostic Signature in Breast Cancer: Regulatory T Cells, Stemness, and Deep Learning for Synergistic Drug Discovery},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26146995}
}
Kostenlos starten →